The 5th annual UK HealthTech conference will take place on 6th December 2016.

Over 300 delegates are expected to come together to understand critical strategic trends that will impact on their businesses. The event offers the latest insights from key opinion leaders as well as a unique opportunity to engage with industry, UK regulatory, the clinical community and funding bodies. Previously attracting delegates from 20 countries and four continents, this valuable day of briefings and networking has global impact and excellent export opportunities.

With 45 exhibitor spaces, UK HealthTech provides an excellent opportunity to showcase the strength and innovation of the healthcare community. During the day, you will be able to visit the exhibition to meet leading companies and key opinion leaders from the academic and clinical communities, specialising in medical technology, biotechnology and pharmaceuticals, across research, manufacturing and healthcare delivery.

Listen to expert speakers, explore the exhibition and embrace excellent networking opportunities at UK HealthTech 2016.

9.00 – 10.00 Plenary Session

John Wilkinson
MHRA
Director of Devices
New Regulations: The way ahead

Bill Cruise
3M Healthcare
Vice President, Western Europe 3M and Medilink UK Chair
Innovation in the Healthcare Sector – some thoughts and experiences

10.30 – 11.30 Early Access to Medicine – A streamlined approach to clinical development

Seshadri Vasan
Public Health England
Senior Business Development Manager
From Ebola to Zika: Accelerating pre/clinical development of repurposed and new countermeasures during emergencies

Chris Harbach
SGS
Validation Manager, Life Sciences
Extractables and Leachables Analysis

Shaun Stapleton
ReNeuron
Head of Regulatory Affairs
The route to approval in a new indication

10.30 – 11.30 The Impact of regulatory changes

Richard Saunders
Ortho-Clinical Diagnostics
International Regulatory Affairs Senior Manager
Medical Device Regulations – An Industry Perspective

Erica Conway
BSI Group
Head of IVD
Impacts of the new IVD Regulation – a Notified Body’s perspective

Michael Branagan-Harris
Device Access UK
CEO
How to accelerate adoption for your MedTech Device into NHS England

Stuart Johnson
Triteq
Business Development Executive
Medical Regulations Market View

11.30 – 12.30 Market Access – UK procurement and an update on innovation initiatives

Andrew Davies
ABHI
Market Access Director
Activities & Issues in Medtech

Naomi Chapman
NHS Clinical Evaluation Team, Department of Health
Clinical Programme Lead/Deputy Chief Nurse
The NHS Clinical Evaluation Team (England) – By the NHS, for the NHS

Phil Bailey
GS1
Industry Engagement Manager, Healthcare
How global standards support the healthcare industry

Chris Doyle
Genshone Transformation Ltd
Managing Director
eProcurement and Serialisation – Master Data is the key

11.30 – 12.30 Innovation Showcase

Michael Graz
Neem Biotech
Managing Director
Scale up and keep your balance

Andrew Mearns Spragg
Jellagen
CEO
Jellyfish Collagen Biomaterials – Next generation collagen for cell culture and med-tech products

Mark Bowman
PulmonIR
CEO
Using Infra-red Spectroscopy to Detect and Monitor Chronic Obstructive Pulmonary Disease

Sumi Thaker
Momentum Bioscience
Commercial Director
Revolutionising Routine Sepsis Diagnostics

Shaun Philips
BBI Solutions
Senior New Product Development Scientist
BBI Solutions: Shaping the future of lateral flow technology

Wayne Harris
Huntleigh Diagnostics
Business Unit Manager
Applying advanced technologies to the management of Lymphoedema

13.30 – 14.30 Plenary Session

Shahid Hanif
ABPI – Association of the British Pharmaceutical Industry
Head of Health Data and Outcomes
Industry perspectives on health data and patient outcomes

David Sheppard
Department of International Trade
Head of Trade, Life Sciences Organisation
What the Department of International Trade can do for you and priorities for the next five years

Peter Whittington
Office for Life Sciences
Assistant Director
The Accelerated Access Review – accelerating access to innovative medical technologies and medicines for NHS patients

Emma Titmus
London Stock Exchange
Business Development Manager
How to Finance High Growth

14.30 – 15.30 Healthcare innovation and patient safety

Ifan Evans
Welsh Government
Head of Healthcare Innovation
NHS Wales approach to innovation and technology adoption

Peter Groves
National Institute for Health and Care Excellence (NICE)
Chairman, Medical Technologies Advisory Committee
The Role of NICE in the Evaluation of Innovative Medical Technology

Chris Gibson
Smartgate Solutions
Strategic Organisational Development & Innovation
Healthcare innovation & patient safety adopting new techniques and innovation

Damian Bridgeman
Qimova
Business Developement Manager UK and Europe
Lets get comfortable – A patient perspective

14.30 – 15.30 New diagnostics, precision medicine and advanced therapies

Paul Smith
OncoTherics
Director of Science
Precision Medicine in the Microenvironment

Daryl Fernandes
Ludger
Chief Executive
Precision Medicine at Ludger: Glycomics, patient stratification and fat bellies

Paul Seaman
Midatech Pharma
Head of Sustained Delivery
Right Time, Right Place; Exploiting Micro and Nano Particulates for Drug Delivery

Fred Jacobs
Astrimmune
CEO
Targeting cancer at every stage

16.00 – 17.00 Support and funding for commercialisation and R&D

David Calder
The Knowledge Transfer Network
Knowledge Transfer Manager Health and Care
Landscape Update – KTN and Innovate UK Support to Businesses

Chris Rowe
Innovate UK
Lead Technologist – Stratified Medicine Innovation Platform
Innovate UK: Health and Life Sciences Sector

Martin McHugh
Microsemi
Technology and Business Development Manager
Leveraging R&D Funding

Corinne Squire
South East Wales Academic Health Science Partnership (SEWAHSP)
Manager
Support for joint working with NHS and Academia

16.00 – 17.00 The Future of Digital Health

Phil Sinclair
Philips
Partner, Philips Healthcare Transformation Services
Jose Fortino
Philips
Patient Monitoring and Connected Care Business Manager
Transforming the patient journey through connected care

Dyfan Searell
Elidir Health
CEO
Realising mobile digital for the NHS – delivering a Connected Healthcare Administration Interface through co-production

David Halliwell
MDT Global Solutions
Managing Director
Developing Innovative Education

Adrian Stavert-Dobson
Safehand Consulting Limited
Clinical Safety Officer
Designing and implementing health IT systems safely

17.00-17.30 Final Panel

Brexit and an ‘Industrial strategy’ for business

View the website for more details of this year’s event.